5.94
price down icon0.17%   -0.010
after-market Handel nachbörslich: 5.94
loading

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
22.18
- 23.34 22.33 17.04
Operating Income/Loss
-27.91
- -29.04 -27.81 -23.23
Nonoperating Income/Loss
1.802
- 1.57 1.997 2.233
Income/Loss From Continuing Operations Before Tax
3.39%
-26.10
-27.02 -27.46 -25.81 -21.00
Income Tax Expense/Benefit
0.026
- 0.018 0.024 0.043
Income/Loss From Continuing Operations After Tax
3.29%
-26.13
-27.02 -27.48 -25.83 -21.04
Net Income/Loss
3.29%
-26.13
-27.02 -27.48 -25.83 -21.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
65.94
- 50.13 0.0956 49.66
Diluted Average Shares
65.94
- 50.13 0.0956 49.66
Basic Earnings Per Share
-0.40
- -0.55 -0.52 -0.42
Diluted Earnings Per Share
-0.40
- -0.55 -0.52 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):